ORIFARM GENERICS HOLDING A/S — Credit Rating and Financial Key Figures

ORIFARM GENERICS HOLDING A/S (CVR number: 27347223) is a company from ODENSE. The company recorded a gross profit of 326.8 mEUR in 2023. The operating profit was 183.1 mEUR, while net earnings were 91.8 mEUR. The profitability of the company measured by Return on Assets (ROA) was 5.1 %, which can be considered decent and Return on Equity (ROE) was 4.3 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 62.8 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. ORIFARM GENERICS HOLDING A/S's liquidity measured by quick ratio was 0.1 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.